Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$52.08
-4.1%
$50.63
$21.34
$58.40
$4.15B-0.151.06 million shs881,281 shs
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$94.64
$94.46
$40.93
$101.28
$3.47B1.87612,158 shsN/A
Oklo Inc. stock logo
OKLO
Oklo
$68.97
+2.7%
$53.01
$5.35
$73.55
$9.62B0.5715.04 million shs15.21 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%+0.99%-5.14%+38.40%+92.32%
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
0.00%0.00%0.00%+4.31%+78.47%
Oklo Inc. stock logo
OKLO
Oklo
0.00%+23.03%+10.82%+213.67%+677.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3.7714 of 5 stars
3.51.00.04.73.30.80.0
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
2.8591 of 5 stars
1.30.02.53.50.62.53.1
Oklo Inc. stock logo
OKLO
Oklo
1.8977 of 5 stars
2.32.00.00.02.53.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3.00
Buy$82.5058.41% Upside
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
2.50
Moderate Buy$71.33-24.63% Downside
Oklo Inc. stock logo
OKLO
Oklo
2.64
Moderate Buy$60.25-12.64% Downside

Current Analyst Ratings Breakdown

Latest AKRO, HEES, and OKLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Oklo Inc. stock logo
OKLO
Oklo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight$73.00
7/15/2025
Oklo Inc. stock logo
OKLO
Oklo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight$73.00
7/11/2025
Oklo Inc. stock logo
OKLO
Oklo
Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$58.00
7/11/2025
Oklo Inc. stock logo
OKLO
Oklo
Daiwa America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/23/2025
Oklo Inc. stock logo
OKLO
Oklo
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$59.00
6/12/2025
Oklo Inc. stock logo
OKLO
Oklo
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$55.00 ➝ $75.00
6/9/2025
Oklo Inc. stock logo
OKLO
Oklo
Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/28/2025
Oklo Inc. stock logo
OKLO
Oklo
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
5/27/2025
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$63.00 ➝ $64.00
5/27/2025
Oklo Inc. stock logo
OKLO
Oklo
CLSA
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOutperform ➝ Moderate Buy$50.00 ➝ $74.00
5/23/2025
Oklo Inc. stock logo
OKLO
Oklo
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$45.00 ➝ $55.00
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/A$10.75 per shareN/A
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$1.46B2.37$14.76 per share6.41$14.66 per share6.46
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/A$2.05 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$252.06M-$1.95N/AN/AN/AN/A-15.19%-13.97%8/8/2025 (Estimated)
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$169.29M$2.4924.0224.58N/A9.47%25.46%5.16%7/29/2025 (Estimated)
Oklo Inc. stock logo
OKLO
Oklo
-$73.62M-$5.41N/AN/AN/AN/A-22.57%-20.19%8/12/2025 (Estimated)

Latest AKRO, HEES, and OKLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Oklo Inc. stock logo
OKLO
Oklo
-$0.12N/AN/AN/AN/AN/A
8/8/2025Q2 2025
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$0.95N/AN/AN/AN/AN/A
7/29/2025Q2 2025
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$0.55N/AN/AN/A$359.60 millionN/A
5/13/2025Q1 2025
Oklo Inc. stock logo
OKLO
Oklo
-$0.11-$0.07+$0.04-$0.07N/AN/A
5/12/2025Q1 2025
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$1.01$0.90+$1.91$0.90N/AN/A
4/29/2025Q1 2025
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$0.66$0.03-$0.63-$0.17$362.60 million$319.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/AN/A
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
$1.101.16%N/A44.18%N/A
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.03
16.80
16.80
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
2.09
0.64
0.59
Oklo Inc. stock logo
OKLO
Oklo
N/A
36.23
36.23

Institutional Ownership

CompanyInstitutional Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
84.08%
Oklo Inc. stock logo
OKLO
Oklo
85.03%

Insider Ownership

CompanyInsider Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
7.07%
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
12.50%
Oklo Inc. stock logo
OKLO
Oklo
18.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3079.72 million74.08 millionOptionable
H&E Equipment Services, Inc. stock logo
HEES
H&E Equipment Services
2,38036.67 million32.03 millionOptionable
Oklo Inc. stock logo
OKLO
Oklo
78139.53 million113.16 millionOptionable

Recent News About These Companies

Brokers Issue Forecasts for Oklo FY2025 Earnings
Oklo (NYSE:OKLO) Shares Down 2.2% - Should You Sell?
Oklo (NYSE:OKLO) Trading Up 1.2% - Here's Why
Best Nuclear Stocks To Follow Now - July 17th
Why Oklo Stock Popped on Thursday
Oklo selects constructor for first Aurora powerhouse
Brokers Set Expectations for Oklo FY2025 Earnings
Oklo (NYSE:OKLO) Upgraded by Cantor Fitzgerald to Overweight Rating
Firm selected to build commercial energy facility at INL
Top Nuclear Stocks To Follow Today - July 16th
Investors Buy Large Volume of Oklo Call Options (NYSE:OKLO)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akero Therapeutics stock logo

Akero Therapeutics NASDAQ:AKRO

$52.08 -2.25 (-4.14%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$52.74 +0.66 (+1.27%)
As of 07/18/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

H&E Equipment Services stock logo

H&E Equipment Services NASDAQ:HEES

H&E Equipment Services, Inc. engages in the provision of equipment services, which focus on heavy construction and industrial equipment. It operates through the following segments: Equipment Rentals, Sales of Rental Equipment, Sales of New Equipment, and Parts, Service and Other Revenues. The Equipment Rentals segment focuses on renting construction and industrial equipment. The Sales of Rental Equipment segment is generated primarily from sales from the rental fleet. The Sales of New Equipment segment sells equipment through a professional sales force. The Parts, Service and Other Revenues segment provides parts to the own rental fleet and sells parts for the equipment. The company was founded by Tom Engquist and Frank Head in 1961 and is headquartered in Baton Rouge, LA.

Oklo stock logo

Oklo NYSE:OKLO

$68.97 +1.80 (+2.68%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$68.45 -0.52 (-0.75%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.